Analysis of differentially expressed mitochondrial proteins in chromophobe renal cell carcinomas and renal oncocytomas by 2-D gel electrophoresis

International Journal of Biological Sciences

Volumn 6, Issue 3, 2010, Pages 213-224

  Yusenko, Maria V ^a   Ruppert, Thomas ^b   Kovacs, Gyula ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

2 D page; Chromophobe renal cell carcinoma; Mass spectrometry; Mitochondria; Renal oncocytoma

Indexed keywords

EID: 77953308190     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.213     Document Type: Article

References (40)

1. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathological feature of 50 cases. J Urol. 1995; 154: 964-967.
2. Davis CJ, Sesterhenn IA, Mostofi FK, et al. Renal oncocytoma. Clinicopathological study of 166 patients. J Urogenital Pathol. 1991; 1: 41-52.
3. Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes Cancer. 1992; 4: 267-268.
4. Speicher MR, Schoell B, du Manoir S, et al. Specific loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridisation. Am J Pathol. 1994; 145: 356-364.
5. Bugert P, Gaul C, Weber K, et al. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. Lab Invest. 1997; 76: 203-208.
6. Wilhelm M, Veltman JA, Olshen A, et al. Array based CGH for the differential diagnosis of renal cell cancer. Cancer Res. 2002; 62: 957-960.
7. Nagy A, Buzogany I, Kovacs G. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes. Histopathology. 2004; 44: 542-546.
8. Yusenko MV, Kuiper RP, Boethe T, et al. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinoma and renal oncocytomas. BMC Cancer. 2009; 9: 152.
9. Füzesi L, Gunawan B, Braun S, et al. Renal oncocytoma with a translocation t(9;11)(p23;q13). J Urol. 2004; 152: 471-472.
10. Contractor H, Zariwala M, Bugert P, et al. Mutation of the p53 tumour suppressor gene occurs preferentially in chromophobe type of renal cell tumours. J Pathol. 1997; 181: 136-139.
11. Sükösd F, Digon B, Fischer J, et al. Allelic loss at chromosome 10q23.3 but lack of mutation of the PTEN/MMAC1 in chromophobe renal cell carcinoma. Cancer Genet Cytogenet. 2001; 128: 161-163.
12. Nagy A, Zubakov D, Stupar Z, et al. Lack of mutation of the folliculin gene in sporadic chromophobe RCC and renal oncocytoma. Int J Cancer. 2004; 109: 472-475.
13. Boer JM, Huber WK, Sültmann H, et al. Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array. Genome Res. 2001; 11: 1861-1870.
14. Takahashi M., Yang XY, Sugimura J, et al. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene. 2003; 22: 6810-6818.
15. Young AN, Amin MB, Moreno CS, et al. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers. Am J Pathol. 2001; 158: 1639-1651.
16. Higgins JPT, Shinghal R, Gill H, et al. Gene Expression Patterns in Renal Cell Carcinoma Assessed by Complementary DNA Microarray. Am J Pathol. 2003; 162: 925-932.
17. Yusenko MV, Zubakov D, Kovacs G. Gene expression profiling of chromophobe renal cell carcinomas and renal oncocytomas by Affymetrix GeneChip using pooled and individual tumours. Int J Biol Sci. 2009; 5: 517-527.
18. Zhuang Z, Huang S, Kowalak JA, et al. From tissue phenotype to proteotype: Sensitive protein identification in microdissected tumor tissue. Int J Oncol. 2006; 28: 103-110.
19. Nagy A, Wilhelm M, Sükösd F, et al. Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer. 2002; 35: 256-260.
20. Welter C, Kovacs G, Seitz G, et al. Alteration of mitochondrial DANN in human oncocytomas. Genes Chromosomes Cancer. 1989; 1: 79-82.
21. Brooks JD, Marshall FF, Isaacs WB, et al. Absence of HinfI restriction abnormalities in renal oncocytoma mitochondrial DNA. Mol Urol. 1999; 3: 1-3.
22. Gasparre G, Hervouet E, de Laplanche E, et al. Clonal expansion of mutated mitochondrial DNA is associated with tumor formation and complex I deficiency in the benign renal oncocytoma. Hum Mol Genet. 2008; 17: 986-995.
23. Simonnet H, Demont J, Pfeiffer K, et al. Mitochondrial complex I is deficient in renal oncocytomas. Carcinogenesis. 2003; 24: 1461-1466.
24. Mayr JA, Meierhofer D, Zimmermann F, et al. Loss of Complex I due to mitochondrial DNA mutations in renal oncocytoma. Clin Cancer Res. 2008; 14: 2270-2275.
25. Heddi A, Faure-Vigny H, Wallace DC, et al. Coordinate expression of nuclear and mitochondrial genes involved in energy production in carcinoma and oncocytoma. Biochim Biophys Acta. 1996; 1316: 203-209.
26. McDonald TG, van Eyk JE. Mitochondrial proteomics. Undercover in the lipid bilayer. Basic Res Cardiol. 2003; 98: 219-227.
27. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997; 183: 131-133.
28. Catrein I, Herrmann R, Bosserhoff A, et al. Experimental proof for a signal peptidase I like activity in Mycoplasma pneumoniae, but absence of a gene encoding a conserved bacterial type I SPase. FEBS J. 2005; 272: 2892-2900.
29. Hartwig S, Feckler C, Lehr S, et al. A critical comparison between two classical and a kit-based method for mitochondria isolation. Proteomics. 2009; 9: 3209-3214.
30. Abbott A. How to spot a protein in a crowd. Nature. 1999; 402: 716-717.
31. Lopez MF, Kristal BS, Chernokalskaya E, et al. High-throughput profiling of the mitochondrial proteome using affinity fractionation and automation. Electrophoresis. 2000; 21: 3427-3440.
32. Gudinot C, de Laplanche E, Hervouet E, et al. Actuality of Warburg's views in our understanding of renal cancer metabolism. J Bioenerg Biomembr. 2007; 39: 235-241.
33. Simonnet H, Alazard N, Pfeiffer K, et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. Carcinogenesis. 2002; 23: 759-768.
34. Hervouet E, Godinot C. Mitochondrial disorders in renal tumors. Mitochondrion. 2006; 6: 105-117.
35. Hervouet E, Simonnet H, Godinot C. Mitochondria and reactive oxygen species in renal cancer. Biochimie. 2007; 89: 1080-1088.
36. Arrigo AP. The cellular networking of mammalian Hsp27 and its functions in the control of protein folding, redox state and apoptosis. Adv Exp Med Biol. 2007; 594: 14-26.
37. Sarto C, Valsecchi C, Magni F, et al. Expression of heat shock protein 27 in human renal cell carcinoma. Proteomics. 2004; 4: 2252-2260.
38. Knowles MK, Guenza MG, Capaldi RA, et al. Cytoskeletal-assisted dynamics of the mitochondrial reticulum in living cells. Proc Natl Acad Sci USA. 2002; 99: 14772-14777.
39. Hallmann A, Milczarek R, Lipinski M, et al. Fast perinuclear clustering of mitochondria in oxidatively stressed human choriocarcinoma cells. Folia Morphol (Warsz). 2004; 63: 407-412.
40. Pletjushkina OY, Lyamzaev KG, Popova EN, et al. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim Biophys Acta. 2006; 1757: 518-524.